peptide e4 Apolipoprotein E4 potentiates amyloid β peptide - Endostatin a piece of protein or peptide derived from endostatin

E4 peptidereddit The peptide E4 is a significant subject in biomedical research, primarily recognized for its potent anti-fibrotic activity.Apolipoprotein E4 Potentiates Amyloid β Peptide-induced ... This peptide, often referred to as E4, is a peptide derivative of the endostatin C-terminus, a fragment originating from a collagen protein. Its ability to prevent and reverse both dermal and pulmonary fibrosis has positioned it as a promising therapeutic agent for fibrotic diseases. Research indicates that E4 peptide exhibits oral bioavailability, making it a potentially convenient option for treatment作者：WQ Qiu·2014·被引用次数：27—ApolipoproteinE4(ApoE4) is the major risk factor for AD with late onset [19]. The ApoE4 allele is associated with BBB damage [20], which likely adversely ....

E4 Peptide: Mechanism and Therapeutic Potential

The E4 peptide's therapeutic promise stems from its mechanism of action as an anti-fibrotic molecule. Studies have shown that it can inhibit the development of fibrotic conditions such as scleroderma and pulmonary fibrosis.Dendritic cell The peptide is derived from endostatin, a component known for its anti-angiogenic properties, and the E4 fragment specifically has demonstrated remarkable efficacy in preclinical models, including those induced by bleomycin. The administration of E4 peptide, even at low doses (e.E4 peptide (20, 10, 5, and 1?g/mouse) or scrambled control peptide (20?g/mouse) was orally administered on the same day as bleomycin. In some experiments ...gE4 peptide (20, 10, 5, and 1?g/mouse) or scrambled control peptide (20?g/mouse) was orally administered on the same day as bleomycin. In some experiments ...., 20, 10, 5, and 1 µg/mouse), has been effective in reversing fibrosis, suggesting a potent and targeted action. Its engagement with cellular targets like uPAR and enolase-1, which activates urokinase, further elucidates its role in modulating fibrotic processes作者：S Sharma·2021·被引用次数：22—We recently demonstrated that the C-terminal domain of endostatin, known as E4,prevents and reverses both dermal and pulmonary fibrosisin ....

Distinguishing E4 Peptide from Other E4 Entities

It is crucial to differentiate the anti-fibrotic E4 peptide from other entities that share the "E4" designation. For instance, apolipoprotein E4 (apoE4) is a well-known genetic risk factor for Alzheimer's disease. ApoE4's role in potentiating amyloid beta peptide-induced lysosomal leakage and apoptosis in neuronal cells highlights a distinct biological function unrelated to fibrosisE4 peptide. Similarly, Adenovirus 9 E4-Orf1 refers to a protein encoded by adenovirus, and peptides derived from it are used in research for blocking antibody activity, not for treating fibrotic conditions. Another entity, Solute carrier family 35 member E4, represents a different protein involved in cellular transport. Finally, UBE4B is an additional conjugation factor, E4, which plays a role in ubiquitin chain assembly. These diverse applications underscore the importance of specifying the context when discussing "peptide E4" to avoid confusion.

Research and Availability of E4 Peptide

The research surrounding the E4 peptide, particularly its anti-fibrotic properties, continues to expand, with publications detailing its efficacy in various experimental models. The peptide has garnered significant attention in biomedical research for its potential therapeutic applications. For researchers interested in studying its effects, E4 peptide and related products are available from scientific supply companies. When seeking to acquire this peptide, terms like "E4 peptide buy," "E4 peptide buy online," and "can you buy E4 peptide" are commonly used in searches, reflecting a strong interest in its accessibility for laboratory and potential clinical investigation. While direct consumer purchase for therapeutic use is not standard, its availability for scientific research is established.

Conclusion

In summary, the peptide E4 is a notable peptide derivative of endostatin that possesses significant anti-fibrotic activity, offering potential therapeutic benefits for conditions like pulmonary and dermal fibrosis. Its mechanism involves preventing and reversing fibrotic processes, and its oral bioavailability adds to its therapeutic appeal. It is essential to distinguish this anti-fibrotic E4 peptide from other entities also designated as E4, such as apolipoprotein E4, Adenovirus 9 E4-Orf1, and Solute carrier family 35 member E4, which have entirely different biological roles.Dendritic cell Ongoing research continues to explore the full therapeutic potential of this promising peptidePeptide E-4.